192 related articles for article (PubMed ID: 29475877)
21. Adrenocortical carcinoma.
Rodgers SE; Evans DB; Lee JE; Perrier ND
Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
[TBL] [Abstract][Full Text] [Related]
22. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
[TBL] [Abstract][Full Text] [Related]
23. Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors.
Gara SK; Lack J; Zhang L; Harris E; Cam M; Kebebew E
Nat Commun; 2018 Oct; 9(1):4172. PubMed ID: 30301885
[TBL] [Abstract][Full Text] [Related]
24. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
[TBL] [Abstract][Full Text] [Related]
25. Clinical management of adrenocortical carcinoma.
Fassnacht M; Allolio B
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):273-89. PubMed ID: 19500769
[TBL] [Abstract][Full Text] [Related]
26. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
Elfiky AA; Krishnan Nair HK
Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
[TBL] [Abstract][Full Text] [Related]
27. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
28. Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma.
Clay MR; Pinto EM; Fishbein L; Else T; Kiseljak-Vassiliades K
J Clin Endocrinol Metab; 2022 Mar; 107(4):1159-1169. PubMed ID: 34850906
[TBL] [Abstract][Full Text] [Related]
29. 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma.
Poli G; Ceni E; Armignacco R; Ercolino T; Canu L; Baroni G; Nesi G; Galli A; Mannelli M; Luconi M
Oncotarget; 2015 Mar; 6(8):5695-706. PubMed ID: 25691058
[TBL] [Abstract][Full Text] [Related]
30. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
31. Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.
Blanes A; Diaz-Cano SJ
Am J Clin Pathol; 2007 Mar; 127(3):398-408. PubMed ID: 17276949
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.
Wanis KN; Kanthan R
World J Surg Oncol; 2015 Mar; 13():117. PubMed ID: 25889798
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis, treatment and outcome of adrenocortical cancer.
Mihai R
Br J Surg; 2015 Mar; 102(4):291-306. PubMed ID: 25689291
[TBL] [Abstract][Full Text] [Related]
34. Current and emerging therapies for adrenocortical carcinoma--review.
Przytulska J; Rogala N; Bednarek-Tupikowska G
Adv Clin Exp Med; 2015; 24(2):185-93. PubMed ID: 25931348
[TBL] [Abstract][Full Text] [Related]
35. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.
Fassnacht M; Johanssen S; Quinkler M; Bucsky P; Willenberg HS; Beuschlein F; Terzolo M; Mueller HH; Hahner S; Allolio B; ;
Cancer; 2009 Jan; 115(2):243-50. PubMed ID: 19025987
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
[TBL] [Abstract][Full Text] [Related]
37. Adrenocortical carcinoma: review and update.
Erickson LA; Rivera M; Zhang J
Adv Anat Pathol; 2014 May; 21(3):151-9. PubMed ID: 24713984
[TBL] [Abstract][Full Text] [Related]
38. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
[TBL] [Abstract][Full Text] [Related]
39. Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.
Ragazzon B; Libé R; Gaujoux S; Assié G; Fratticci A; Launay P; Clauser E; Bertagna X; Tissier F; de Reyniès A; Bertherat J
Cancer Res; 2010 Nov; 70(21):8276-81. PubMed ID: 20959480
[TBL] [Abstract][Full Text] [Related]
40. Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation.
Hantel C; Shapiro I; Poli G; Chiapponi C; Bidlingmaier M; Reincke M; Luconi M; Jung S; Beuschlein F
Oncotarget; 2016 Nov; 7(48):79292-79304. PubMed ID: 27764813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
